CV Sciences, Inc. (OTCMKTS:CVSI) Short Interest Update

CV Sciences, Inc. (OTCMKTS:CVSI) was the recipient of a large decrease in short interest during the month of December. As of December 31st, there was short interest totalling 6,400 shares, a decrease of 82.5% from the December 15th total of 36,600 shares. Based on an average trading volume of 697,100 shares, the days-to-cover ratio is currently 0.0 days.

CV Sciences Trading Down 12.8 %

Shares of OTCMKTS:CVSI traded down $0.00 on Tuesday, hitting $0.03. The company had a trading volume of 768,223 shares, compared to its average volume of 398,140. CV Sciences has a 1-year low of $0.03 and a 1-year high of $0.10. The stock has a market cap of $5.54 million, a price-to-earnings ratio of -3.00 and a beta of 0.66. The stock has a 50 day moving average price of $0.04 and a 200 day moving average price of $0.05.

CV Sciences Company Profile

CV Sciences, Inc develops, manufactures, markets, and sells herbal supplements and hemp-based cannabidiol (CBD) in North America. It operates in two segments, Consumer Products and Specialty Pharmaceutical. The company offers its products under the PlusCBD, ProCBD, HappyLane, CVAcute, CVDefense, and PlusCBD Pet brands in the health care market sector, including nutraceutical, beauty care, specialty foods, and pet products through its websites, elect distributors, brick and mortar retailers, and select e-tailers.